He told pharmaphorum: "In 1668, the aspiring pharmacist Friedrich Jacob Merck laid our foundations, making us the world’s oldest pharmaceutical and chemical company. His descendants helped pave ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

Merck swung to a fourth-quarter profit as sales ... adjusted earnings per-share of around $9.13 in 2025. Write to Denny Jacob at [email protected] About Dow Jones Newswires Dow Jones Newswires ...

Merck swung to a quarterly profit as sales grew ... Winrevair launched in the U.S. in the second quarter. Write to Denny Jacob at [email protected] We sell different types of products and ...

Merck swung to a fourth-quarter profit as sales ... adjusted earnings per-share of around $9.13 in 2025. Write to Denny Jacob at [email protected] We sell different types of products and ...

Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, although the drug company’s outlook for 2025 ...

For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda climbed 19% to $7.84 billion.

Merck’s Q4 sales rose 7% YoY to $15.62B, slightly beating the $15.49B consensus. Adjusted EPS jumped to $1.72, topping estimates of $1.62. Keytruda sales grew 19% YoY to $7.84B, while Gardasil ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted earnings per share for the year to range from $8.88 to ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Merck shares tumbled after the drugmaker said it was halting shipments of a top-selling vaccine to China to ...

Merck achieved revenue growth in Q4, but stocks tumbled Tuesday amid news that the company is pausing Gardasil shipments to China. © 2024 Fortune Media IP Limited ...